Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
OpenUpdated: Oct 30, 2025
Summary
The grant aims to support innovative mechanistic research for precision probiotic interventions through a biphasic award mechanism (R61/R33), focusing on identifying person-specific features that affect probiotic responses. Eligible applicants include public and private higher education institutions, nonprofits, government entities, and for-profit organizations, among others. To apply, interested parties should follow the guidelines outlined in the full opportunity announcement, which includes specific requirements for the R61 and R33 phases.
Full Description
Description
Eligibility
Eligible applicants
Education
- Public and state institutions of higher education
- Private institutions of higher education
- Independent school districts
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
Government
- Special district governments
- Public and Indian housing authorities
- County governments
- City or township governments
- Federally recognized Native American tribal governments
- State governments
Miscellaneous
- Other
Business
- For-profit organizations other than small businesses
- Small businesses
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.